News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Vall d'Hebron highlights the potential of synbiotics to control irritability 22/07/2024 Genetic basis of ADHD and autism spectrum disorder impacts on school performance 31/05/2024 Dr. Rafael Simó receives the Eva Kohner Award for his career in research 15/06/2023 A genetic study indicates that ADHD is associated with lower life expectancy 09/05/2023 D-Sight, a Vall d’Hebron spin-off, raises €1M to develop a new drug 02/05/2023 The Spanish Diabetes Society awards the career of Dr. Rafael Simó 21/04/2023 Largest genetic study in ADHD identifies new genome regions associated with the disorder 24/02/2023 Vall d'Hebron has participated in the creation of a guide for the treatment of the reflux 16/02/2023 Four Vall d’Hebron mental health projects awarded in the 2021 TV3 La Marató charity event 03/11/2022 Dr Amanda Rodríguez presents her book 'Siente lo que comes' 05/04/2022 New study shows the relationship between insomnia and ADHD improvement 03/03/2022 A Vall d’Hebron study relates the impact of obesity to cognitive impairment 26/01/2022 Vall d'Hebron identifies that patients with diabetes and myocardial insulin resistance have high cardiovascular risk 24/01/2022 New report with the collaboration of Vall d’Hebron calls for clearer definition of treatment-resistant depression 15/12/2021 Vall d'Hebron studies the effectiveness of online interventions for cannabis addiction in young people 07/12/2021 Vall d’Hebron and IDIAP Jordi Gol join forces to research cardiovascular diseases and diabetes 30/11/2021 Families with transplanted children feel more understood due to the widespread use of prevention measures, such as masks 15/09/2021 Two VHIR researchers have received awards at the Catalan Health Institute's 2021 Research Awards 27/06/2021 Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat 16/06/2021 Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder 16/05/2021 Pagination 1 2 Next › Next page Last » Last page